HLA-A2 PBMC from three melanoma patients known to have a positive clinical response was analyzed for IFNγ response by real time RT-PCR. IFNγ response fold increase over HIV, (IFNγ peptide/CD8)/(IFNγ HIV/CD8), is shown. The gene discussed is CD8A; the disease is melanoma.